Links
[1] https://www.msh.org/our-work/health-area/90/resources?page=6&field_resource_type_value=All&items_per_page=25&order=title&sort=asc
[2] https://www.msh.org/our-work/health-area/90/resources?page=6&field_resource_type_value=All&items_per_page=25&order=field_resource_type&sort=asc
[3] https://www.msh.org/our-work/health-area/90/resources?page=6&field_resource_type_value=All&items_per_page=25&order=created&sort=desc
[4] https://www.msh.org/resources/pharmacovigilance-and-global-hivaids
[5] https://www.msh.org/our-work/health-area/hiv-aids
[6] https://www.msh.org/resources/improving-data-quality-and-supervision-of-antiretroviral-therapy-sites-in-malawi-an
[7] https://www.msh.org/resources/analysis-of-hiv-early-infant-diagnosis-data-to-estimate-rates-of-perinatal-hiv
[8] https://www.msh.org/resources/mortality-and-health-outcomes-in-hiv-infected-and-hiv-uninfected-mothers-at-18%E2%80%9320-months
[9] https://www.msh.org/resources/how-operational-research-influenced-the-scale-up-of-antiretroviral-therapy-in-malawi
[10] https://www.msh.org/resources/mortality-and-health-outcomes-of-hiv-exposed-and-unexposed-children-in-a-pmtct-cohort-in
[11] https://www.msh.org/resources/enhancing-the-role-of-pharmacists-in-public-health-in-developing-countries
[12] https://www.msh.org/our-work/health-area/malaria
[13] https://www.msh.org/our-work/health-area/tuberculosis
[14] https://www.msh.org/resources/strengthening-the-appointment-and-tracking-systems-for-patients-on-antiretroviral-therapy
[15] https://www.msh.org/resources/cost-effectiveness-analysis-of-option-b-for-hiv-prevention-and-treatment-of-mothers-and
[16] https://www.msh.org/resources/existing-capacity-to-manage-pharmaceuticals-and-related-commodities-in-east-africa-an
[17] https://www.msh.org/our-work/health-system/pharmaceutical-management
[18] https://www.msh.org/resources/community-health-workers-for-art-in-sub-saharan-africa-learning-from-experience-%E2%80%93
[19] https://www.msh.org/resources/pilot-assessment-of-supply-chains-for-pharmaceuticals-and-medical-commodities-for-malaria
[20] https://www.msh.org/resources/records-linkage-of-electronic-databases-for-the-assessment-of-adverse-effects-of
[21] https://www.msh.org/resources/implications-of-adopting-new-who-guidelines-for-art-initiation-in-ethiopia-policy-and
[22] https://www.msh.org/resources/measuring-adherence-to-antiretroviral-treatment-in-resource-poor-settings-the-feasibility
[23] https://www.msh.org/resources/the-experiences-of-people-living-with-hivaids-and-of-their-direct-informal-caregivers-in-a
[24] https://www.msh.org/resources/rpm-plus-malaria-brochure
[25] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies
[26] https://www.msh.org/resources/changing-malaria-treatment-policy-to-artemisinin-based-combinations-an-implementation
[27] https://www.msh.org/resources/best-practices-in-the-integration-of-tb-and-hivaids-services
[28] https://www.msh.org/resources/a-role-model-for-family-planning
[29] https://www.msh.org/resources/the-risk-factor-profile-of-women-with-secondary-infertility-an-unmatched-case-control
[30] https://www.msh.org/resources/antiretroviral-drug-supply-challenges-in-the-era-of-scaling-up-art-in-malawi
[31] https://www.msh.org/resources/hiv-related-conspiracy-beliefs-and-its-relationships-with-hiv-testing-and-unprotected-sex
[32] https://www.msh.org/resources/why-did-the-scale-up-of-hiv-treatment-work-a-case-example-from-malawi
[33] https://www.msh.org/our-work/health-area/90/resources
[34] https://www.msh.org/our-work/health-area/90/resources?page=5
[35] https://www.msh.org/our-work/health-area/90/resources?page=1
[36] https://www.msh.org/our-work/health-area/90/resources?page=2
[37] https://www.msh.org/our-work/health-area/90/resources?page=3
[38] https://www.msh.org/our-work/health-area/90/resources?page=4
[39] https://www.msh.org/our-work/health-area/90/resources?page=7